Vamorolone Demonstrates On-Target Glucocorticoid Activity Without The Immunosuppression Characteristic Of Traditional Corticosteroids At Clinical Doses

Catalyst Pharmaceuticals Inc NASDAQ:CPRX:

• VAMOROLONE DEMONSTRATES ON-TARGET GLUCOCORTICOID ACTIVITY WITHOUT THE IMMUNOSUPPRESSION CHARACTERISTIC OF TRADITIONAL CORTICOSTEROIDS AT CLINICAL DOSES

• CATALYST PHARMACEUTICALS - VAMOROLONE SHOWS NO SIGNIFICANT IMMUNOSUPPRESSION AT CLINICAL DOSES IN PHASE 1 STUDY